Challenges in studying the structures of metal-amyloid oligomers related to type 2 diabetes, Parkinson's disease, and Alzheimer's disease

•There are challenges to observe the structures of metal-amyloid oligomers by experimental tools at the atomic resolution.•Computational studies may assist in proposing these conformations.•Various conformational models of metal-amyloid binding sites should be investigated.